|
Monreal Bernal A, Berenguer Piqueras M, Ortiz Salvador P, Suarez Terron M, Bataller Alfonso A, Delgado Palacio S, Senent Peris ML, Roig Pellicer M, Villalba Valenzuela A, Benet Campos C, Espinosa Arnandi C, Fernandez Poveda E, Salido Fierez E, Rodenas Quinonero I, de Arriba de la Fuente F, Ortiz Andrade J, Marco Ayala J, Lozano ML, Ortuno FJ. Visceral leishmaniasis in heavily pretreated multiple myeloma patients a case series of 17 patients from the Mediterranean Coast of Spain. Ann Med. 2025 Dec;57(1):2514075. doi: 10.1080/07853890.2025.2514075. Epub 2025 Jun 5. PubMed PMID: 40470770; PubMed Central PMCID: PMC12143001.
AÑO: 2025; IF: 4.3
|
40470770
|
Lasa M, Gonzalez C, Notarfranchi L, Zherniakova A, Alignani D, Burgos L, Calasanz MJ, Rodriguez-Otero P, Perez JJ, Gomez C, Gonzalez de la Calle V, de Arriba F, Palomera L, Alvarez Rivas MA, Clavero E, Ocio EM, Gonzalez-Rodriguez AP, Lakhwani S, Ibanez A, Oriol A, Sureda A, Rosinol L, Siewert C, Orfao A, Lahuerta JJ, Blade J, Mateos MV, San-Miguel JF, Cedena MT, Martinez-Lopez J, Puig N, Paiva B. Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment. Blood. 2025 Aug 21;146(8):964-970. doi: 10.1182/blood.2025029234. PubMed PMID: 40403320.
AÑO: 2025; IF: 23.1
|
|
Moreno DF, Oriol A, de la Rubia J, Hernandez MT, Inigo MB, Palomera L, de Arriba F, Gonzalez Y, Teruel AI, Pardo JL, Lopez de la Guia A, Sampol A, Rios-Tamayo R, Sureda A, Gutierrez NC, Calasanz MJ, Ramos MLM, Mateos MV, San Miguel J, Lahuerta JJ, Blade J, Rosinol L; PETHEMA/GEM group. Is t(11;14) Always a Standard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Transplantation Trials. Clin Lymphoma Myeloma Leuk. 2025 Jul;25(7):494-504. doi: 10.1016/j.clml.2025.01.014. Epub 2025 Jan 25. PubMed PMID: 39955256.
AÑO: 2025; IF: 2.7
|
|
Lasa M, Notarfranchi L, Agullo C, Gonzalez C, Castro S, Perez JJ, Burgos L, Guerrero C, Calasanz MJ, Flores-Montero J, Oriol A, Bargay J, Rios R, Cabanas V, Cabrera C, Martinez-Martinez R, Encinas C, De Arriba F, Hernandez MT, Palomera L, Orfao A, Martinez-Lopez J, Mateos MV, San-Miguel J, Lahuerta JJ, Rosinol L, Blade J, Cedena MT, Puig N, Paiva B; PETHEMA/GEM Cooperative Group. Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma. J Clin Oncol. 2025 Jan 10;43(2):125-132. doi: 10.1200/JCO.24.00635. Epub 2024 Oct 1. PubMed PMID: 39353166.
AÑO: 2025; IF: 41.9
|
|
Guerrero C, Larrayoz MJ, Erdozain I, Puig N, Cedena MT, Maia C, Manu A, Gordillo N, Churruca O, Alignani D, Sarvide S, Vazquez I, Perez C, Oriol A, Rosinol L, Rios-Tamayo R, Gonzalez-Perez MS, Gonzalez-Rodriguez AP, de Arriba F, Moraleda JM, Martin J, Palomera L, Cabanas V, Calasanz MJ, Martinez-Lopez J, Mateos MV, Blade J, Lahuerta JJ, San-Miguel JF, Paiva B. Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma. Blood Cancer Discov. 2025 May 5;6(3):203-216. doi: 10.1158/2643-3230.BCD-24-0274. PubMed PMID: 40232156; PubMed Central PMCID: PMC12050965.
AÑO: 2025; IF: 11.5
|